To study the effect of intravenous dexmedetomidine in prolonging spinal anaesthesia in infraumblical surgeries

To study the efficacy of intravenous dexmedetomidine in prolonging spinal anaesthesia in infraumblical surgeries - nil

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099726

Enrollment

Registered

2025-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system Health Condition 2: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: To study the efficacy of intravenous dexmedetomidine in prolonging spinal anaesthesia in infraumblical surgeries: Patient given 3ml 0.5% BUPIVACAINE with 0.5mcg/kg dexmeditomidine in 10

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II. Age between 18-60 years All infra umbilical elective surgeries

Exclusion criteria

Exclusion criteria: Patient refusal. Age less than 18 and more than 60 years . ASA grade 3&4. Severe hepatic or renal failure Patient with known allergy to LA drugs Patients suffering from IHD, angina , arrhythmias, heart block, Previous MI. Patients with contraindication to spinal anaesthesia.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of intravenous dexmedetomidine on the duration of sensory and motor blockade.Timepoint: From zero minutes to three hours of surgery	—

Secondary

Measure	Time frame
To study hemodynamic profile and the level of sedation following dexmedetomidineTimepoint: from zero minutes to three hours of surgery	—

Countries

India

Contacts

Public ContactDrkrishnappreya

vinayaka mission medical college and hospital ,salem

nimmu1335@gmail.com09487873738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026